SCHEMBL29044252

SCHEMBL29044252

CNC(=O)[C@H]1CC(O)CN1C(=O)OC(C)(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2C19 P33261 1/20 0.58
HTRA1 Q92743 1/20 0.44
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
VHL P40337 1/20 0.43
PTPN1 P18031 1/20 0.42
ATM Q13315 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
NR1H2 P55055 1/20 0.37
ALDH1A1 P00352 1/20 0.36
HSD11B1 P28845 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24441127 1.00 POLB (0.58) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL29044251 1.00 POLB (0.58) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL12062318 0.88 CYP1A2 (0.46) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL16857324 0.87 CYP1A2 (0.46) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL21026849 0.87 CYP1A2 (0.46) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL16857326 0.87 CYP1A2 (0.46) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL16857327 0.87 CYP1A2 (0.46) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL21026968 0.87 CYP1A2 (0.46) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL6319198 0.87 POLB (0.57) POLBCYP1A2CYP3A4CYP2C19HTRA1
SCHEMBL8907775 0.87 POLB (0.57) POLBCYP1A2CYP3A4CYP2C19HTRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116507617-A 1- (2- (4-cyclopropyl-1H-1, 2, 3-triazol-1-yl) acetyl) -4-hydroxypyrrolidine-2-carboxamide derivatives as VHL inhibitors for the treatment of anaemia 基因泰克公司 2023-07-28 CN disclosed